SANGAMO THERAPEUTICS, INC Insider Trading for October 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC for October 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 7.28 | 10,000 | 72,800 | 0 | |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.02 | 10,000 | 120,153 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 7.28 | 10,000 | 72,800 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Gift | G | 0.00 | 2,500 | 0 | 214,660 | 217.2 K to 214.7 K (-1.15 %) |
| Oct 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 50,000 | |
| Oct 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.49 | 25,000 | 262,365 | 295,000 | 320 K to 295 K (-7.81 %) |
| Oct 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Oct 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.10 | 2,000 | 20,200 | 214,347 | 216.3 K to 214.3 K (-0.92 %) |
| Oct 08 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 15,000 | 61,650 | 6,798 | |
| Oct 08 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.72 | 15,000 | 160,865 | 96,579 | 111.6 K to 96.6 K (-13.44 %) |
| Oct 08 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 15,000 | 61,650 | 111,579 | 96.6 K to 111.6 K (+15.53 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 60,000 | |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 40,500 | |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 2,000 | |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 10.80 | 15,000 | 162,029 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |